Corona Remedies raises Rs 195 crore from 15 anchor investors for Rs 655 crore IPO

• Corona Remedies raised Rs 194.85 crore from 15 anchor investors ahead of its Rs 655-crore IPO.
• The IPO is entirely an offer-for-sale, with no fresh issue component, and is open for public subscription from December 8-10.
• Anchor investors were allocated 18.34 lakh shares at the upper price band of Rs 1,062 per share.
• Domestic mutual funds like SBI MF, ICICI Prudential MF, and Kotak Mahindra AMC were among the anchor investors.
• The pharmaceutical company, valued at Rs 6,495 crore, will debut on December 15.

Why It Matters: This IPO offers a new investment opportunity in the pharma sector.